Your browser doesn't support javascript.
loading
CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy.
Wang, Yizheng; Wang, Linan; Seo, Naohiro; Okumura, Satoshi; Hayashi, Tae; Akahori, Yasushi; Fujiwara, Hiroshi; Amaishi, Yasunori; Okamoto, Sachiko; Mineno, Junichi; Tanaka, Yoshimasa; Kato, Takuma; Shiku, Hiroshi.
Afiliação
  • Wang Y; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.
  • Wang L; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.
  • Seo N; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.
  • Okumura S; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.
  • Hayashi T; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.
  • Akahori Y; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.
  • Fujiwara H; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.
  • Amaishi Y; Takara Bio Inc., Kusatsu 525-0058, Shiga, Japan.
  • Okamoto S; Takara Bio Inc., Kusatsu 525-0058, Shiga, Japan.
  • Mineno J; Takara Bio Inc., Kusatsu 525-0058, Shiga, Japan.
  • Tanaka Y; Center for Medical Innovation, Nagasaki University, Nagasaki 852-8588, Sakamoto, Japan.
  • Kato T; Cellular and Molecular Immunology, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.
  • Shiku H; Department of Personalized Cancer Immunotherapy, Mie University Graduate School of Medicine, Tsu 514-8507, Mie, Japan.
Int J Mol Sci ; 24(13)2023 Jun 29.
Article em En | MEDLINE | ID: mdl-37446055

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Transplante de Células-Tronco Hematopoéticas / Receptores de Antígenos Quiméricos / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pró-Fármacos / Transplante de Células-Tronco Hematopoéticas / Receptores de Antígenos Quiméricos / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article